A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery
saphenous vein
03 medical and health sciences
0302 clinical medicine
risk factor
RC666-701
coronary artery bypass grafting
Diseases of the circulatory (Cardiovascular) system
graft occlusion
Cardiovascular Medicine
coronary artery disease
3. Good health
DOI:
10.3389/fcvm.2021.670045
Publication Date:
2021-08-12T06:21:33Z
AUTHORS (9)
ABSTRACT
Objectives: Coronary artery bypass grafting (CABG) success is reduced by graft occlusion. Understanding factors associated with occlusion may improve patient outcomes. The aim of this study was to develop a predictive risk score for saphenous vein (SVG) after CABG. Methods: This retrospective cohort enrolled 3,716 CABG patients from January 2012 March 2013. development included 2,477 and the validation 1,239 patients. baseline clinical data at index analyzed their independent impact on in our using Cox proportional hazards regression. scoring tool weighted beta coefficients final model. Concordance (c)-statistics comparison predicted observed probabilities were used discrimination calibration. Results: A total 959 (25.8%) out developed least one late SVG Significant female sex [beta (β) = 0.52], diabetes (β 0.21), smoking (currently) 0.32), hyperuricemia 0.22), dyslipidemia 0.52), prior percutaneous coronary intervention (PCI) rising number 0.12) lesion vessels 0.45). On-pump surgery −0.46) use angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) −0.59) calcium channel (CCB) −0.23) protective factors. 11 variables derivation cohort, which delineated each into quartiles. c-statistic model 0.71 cohort. Conclusions: An easy-to-use sex, diabetes, smoking, hyperuricemia, dyslipidemia, PCI, vessels, on-pump surgery, ACEI/ ARB CCB validated. accurately estimated (c-statistic 0.71).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....